Cas 1111733-72-2,2-Benzoimidazol-1-yl-N-(3,4-dimethyl-phenyl)-N-[2-(4-trifluoromethyl-phenyl)-ethyl]-acetamide

1111733-72-2

Post Buying Request

Basic information

Product Name: 2-Benzoimidazol-1-yl-N-(3,4-dimethyl-phenyl)-N-[2-(4-trifluoromethyl-phenyl)-ethyl]-acetamide
Synonyms: 2-Benzoimidazol-1-yl-N-(3,4-dimethyl-phenyl)-N-[2-(4-trifluoromethyl-phenyl)-ethyl]-acetamide
CAS NO:1111733-72-2
Molecular Formula:
Molecular Weight: 451.491
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2-Benzoimidazol-1-yl-N-(3,4-dimethyl-phenyl)-N-[2-(4-trifluoromethyl-phenyl)-ethyl]-acetamide(CAS DataBase Reference)
NIST Chemistry Reference: 2-Benzoimidazol-1-yl-N-(3,4-dimethyl-phenyl)-N-[2-(4-trifluoromethyl-phenyl)-ethyl]-acetamide(1111733-72-2)
EPA Substance Registry System: 2-Benzoimidazol-1-yl-N-(3,4-dimethyl-phenyl)-N-[2-(4-trifluoromethyl-phenyl)-ethyl]-acetamide(1111733-72-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1111733-72-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1111733-72-2 Suppliers

Recommended suppliers

1111733-72-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1111733-72-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,1,1,7,3 and 3 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1111733-72:
(9*1)+(8*1)+(7*1)+(6*1)+(5*7)+(4*3)+(3*3)+(2*7)+(1*2)=102
102 % 10 = 2
So 1111733-72-2 is a valid CAS Registry Number.

1111733-72-2Upstream product

1111733-72-2Downstream Products

1111733-72-2Relevant academic research and scientific papers

MONOAMIDE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS

-

Page/Page column 92, (2009/03/07)

The present invention relates to compounds of formulawherein Ar, R1, R2, R3, R4, R5, n, o, and p are as defined herein or to pharmaceutically suitable acid addition salts, optically pure enantiomers, racemates or diastereomeric mixtures thereof. The compounds of formula I can be used for the treatment of sleep disorders, such as sleep apnea, narcolepsy, insomnia, parasomnia, jet lag syndrome, circadian rhythms disorder or sleep disorders associated with neurological diseases.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1111733-72-2